Ivermectin and COVID-19 in Care Home: Case Report
Small quasi-randomized (patient choice) study with 25 PCR+ patients in a nursing home offered ivermectin, of which 10 chose to be treated. The mean age was 83.5 in the treatment group and 81.8 in the control group. There was lower mortality and fewer serious cases with treatment.
risk of death, 70.0% lower, RR 0.30, p = 0.34, treatment 1 of 10 (10.0%), control 5 of 15 (33.3%), NNT 4.3.
|
risk of severe case, 55.0% lower, RR 0.45, p = 0.11, treatment 3 of 10 (30.0%), control 10 of 15 (66.7%), NNT 2.7.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Loue et al., 17 Apr 2021, retrospective quasi-randomized (patient choice), France, peer-reviewed, 2 authors, dosage 200μg/kg single dose.
Abstract: ISSN: 2474-3658
Loué and Fardeau. J Infect Dis Epidemiol 2021, 7:202
DOI: 10.23937/2474-3658/1510202
Volume 7 | Issue 4
Open Access
Journal of
Infectious Diseases and Epidemiology
Case Report
Ivermectin and COVID-19 in Care Home: Case Report
Pierre Loué1 and Christine Fardeau2*
Care Home EHPAD, Scarron, Fontenay aux Roses, France
Department of Ophthalmology, Reference Center for Rare Diseases, La Pitié-Salpêtrière Hospital, ParisSorbonne University, France
1
2
Check for
updates
*Corresponding authors: Christine Fardeau, Department of Ophthalmology, Reference Center for Rare Diseases, La PitiéSalpêtrière Hospital, Paris-Sorbonne University, 47-83 Boulevard de l'Hôpital, 75013 Paris, France
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit